6533b82cfe1ef96bd128ed6c

RESEARCH PRODUCT

Transarterial Chemoembolization in Patients Not Eligible for Liver Transplantation: Single-Center Results

Gerd OttoInga KummerChristoph DüberM. SchuchmannJ. SchneiderMichael B. PittonSascha HerberNicole Manzl

subject

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularPalliative careMitomycinmedicine.medical_treatmentContrast MediaLiver transplantationSingle CenterStatistics NonparametricmedicineHumansRadiology Nuclear Medicine and imagingIn patientChemoembolization TherapeuticSurvival analysisAgedAged 80 and overAntibiotics AntineoplasticChi-Square Distributionbusiness.industryLiver NeoplasmsPalliative CareIodized OilGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysisIopamidolSurgeryVenous thrombosisTreatment OutcomeHepatocellular carcinomaFemaleRadiologyTomography X-Ray ComputedbusinessChi-squared distribution

description

OBJECTIVE. The purpose of this study was to evaluate the effectiveness of transarterial chemoembolization in the care of patients not eligible for liver transplantation.CONCLUSIONS. Prognosis depends on local response, Okuda score, α-fetoprotein level, and tumor size and is independent of the presence of portal venous thrombosis.

https://doi.org/10.2214/ajr.07.2755